Please login to the form below

Medical affairs - a strategic function for scientific engagement

The shift in dynamics between medical affairs and commercial teams

David Youds, CEO, Bedrock Group

The function of Medical Affairs has evolved over the years, and continues to do so at quite a pace. The traditional dynamic between Medical Affairs and Commercial teams has been one of restriction, with regulations on “promotional” activities. However, in more recent times there has been a shift towards an increasingly shared responsibility between Commercial and Medical Affairs teams based on mutual values of patient centricity, value propositions and the use of data.

Medical Affairs has always been a vital conduit of information both inwards and outwards. Partnerships between Medical Affairs and external stakeholders are invaluable and provide insights that can steer future medical strategy. The increasing focus of these external stakeholders on proactive communication  has driven Medical Affairs teams to be more forward-looking and ensure a greater understanding of the needs and preferences of their internal and external audiences.

As a result of these shifting dynamics, and in a world with better informed audiences than ever before, the scope of deliverables, availability of new technology and the relative size of medical budgets has changed. Correspondingly, strategic input from Medical Affairs is in demand now more than ever.

As has been said many times “with great power comes great responsibility”. There is increasing responsibility for Medical Affairs to be proactive, address data gaps, be patient-focused, creative, understand channel choice, and deliver behaviour change in addition to their more traditional role in medical and scientific information. This means new skills and new internal partnerships are required.

Most importantly, Medical Affairs needs to assert itself as a strategic co-leader of any pharmaceutical product. There are too many examples of sub-optimal collaboration between commercial and medical departments, often blamed on compliance and the need for ‘firewalls’. While an element of this argument holds true, with the right mindset in place and an early start on strategic alignment across internal functions, many of these barriers can be overcome. The value of this collaborative approach for health systems, and ultimately patients, is huge.

David Youds, CEO, Bedrock Group /

13th May 2020



Company Details

Bedrock Group

01252 240200

Contact Website

One Fleet
Ancells Road
GU51 2UN

Latest content on this profile

Bedrock’s strong start to 2021
Just two months into the year and at Bedrock we’ve already added FOUR new people to an ever-growing team!
Bedrock Group
Why we need to look at rare diseases in a different way
28 February 2021, Rare Disease Day aims to raise awareness of rare diseases and the impact they have on patients’ lives.
Bedrock Group
The Unknown Unknowns
Patient insights are fundamental to ensuring we understand the reality of living with a condition. We need to consciously  challenge our approach and ensure we are unearthing authentic patient insights that change thinking and enhance programmes.
Bedrock Group
Do you know what PoTS is?
As part of Dysautonomia Awareness Month, Origins continues its efforts in raising awareness and understanding of Postural Tachycardia Syndrome (PoTS), a Dysautonomia condition affecting young women that can be very disabling.
Bedrock Group
Leadership change within Bedrock Group
Marie Little appointed Managing Director of Bedrock Healthcare Communications Limited
Bedrock Group
Origins Insights: views from the team
First in a video series from the Origins Insights team discussing some of our views, experiences, values and opinions across many aspects of qualitative patient research activities.
Bedrock Group